Coya Therapeutics Inc. (COYA)
NASDAQ: COYA
· Real-Time Price · USD
5.70
-0.01 (-0.18%)
At close: Jun 05, 2025, 3:59 PM
6.00
5.36%
After-hours: Jun 05, 2025, 04:25 PM EDT
-0.18% (1D)
| Bid | 5.3 |
| Market Cap | 95.25M |
| Revenue (ttm) | 3.69M |
| Net Income (ttm) | -17.14M |
| EPS (ttm) | -1.07 |
| PE Ratio (ttm) | -5.32 |
| Forward PE | -2.88 |
| Analyst | Buy |
| Ask | 6 |
| Volume | 23,173 |
| Avg. Volume (20D) | 69,292 |
| Open | 5.84 |
| Previous Close | 5.71 |
| Day's Range | 5.70 - 5.92 |
| 52-Week Range | 4.65 - 10.24 |
| Beta | 0.21 |
About COYA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol COYA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for COYA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+7.2%
Coya Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
7 months ago
-27.67%
Coya Therapeutics shares are trading lower. The company announced results from the placebo-controlled Phase 2 clinical trial of LD IL-2 in patients with mild to moderate Alzheimer's Disease.
4 weeks ago · businesswire.com
Coya Therapeutics to Participate in Two Upcoming Conferences in May 2025HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) fun...
